RJ009

N/A

Report date: 2023/03/09 16:06:52

Base Information

Drug NameRJ009
Drug Alias NameRJ009RJ-009
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRisen(Shanghai) Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRisen(Shanghai) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A